Become a worldwide leader in DNA based therapies
for food and companion animals utilizing proprietary plasmid based
DNA delivery and expression technology thereby optimizing the animal's
natural biological and immunological potential.
Strategic Intent
| |
 |
Launch the
company's first commercial product by the end of 2007.
|
| |
|
Create a financially independent
animal health company that delivers long term value to shareholders.
|
| |
|
Seek and establish strategic
alliances in global market segments to leverage and commercialize
proprietary GHRH technology in major food and companion animals.
|
| |
|
Develop a broad range
of DNA based products in every major food and companion animal
species.
|
| |
|
Build an image of bringing
products to market that meet significant unmet needs in improving
animal health and economics. |
